ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $16,247,000 | +135291.7% | 94,406 | +101411.8% | 0.02% | – |
| Q4 2020 | $12,000 | -99.9% | 93 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $9,453,000 | -30.5% | 370,424 | +3.6% | 0.02% | -39.5% |
| Q1 2015 | $13,603,000 | -8.6% | 357,413 | -6.4% | 0.04% | -7.3% |
| Q4 2014 | $14,875,000 | +22.6% | 381,805 | -4.8% | 0.04% | +13.9% |
| Q3 2014 | $12,131,000 | -13.3% | 401,170 | -2.6% | 0.04% | -10.0% |
| Q2 2014 | $13,988,000 | +40.6% | 411,781 | +42.8% | 0.04% | +42.9% |
| Q1 2014 | $9,949,000 | – | 288,374 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |